mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
After the genome sequence of SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) was published and the number of infected people began to increase rapidly, many global companies began to develop a vaccine. Almost all known approaches to vaccine design were applied for this purpose,...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
2020-12-01
|
| Serie: | Вавиловский журнал генетики и селекции |
| Ämnen: | |
| Länkar: | https://vavilov.elpub.ru/jour/article/view/2824 |